2024 International Congress Archives - Page 104 of 181

Balance evaluation and vestibular rehabilitation in patients with Hereditary Spastic Paraplegia – randomized clinical trial

G. Dos Santos, M. Severiano, C. de Araújo, F. Magno, B. Zeigelboim, H. Teive (Curitiba, Brazil)
Balancing Act: Smartphone Data and Machine Learning in Movement Disorder Classification

S. Macneille, A. Kostic, A. Chu, J. Daneault (Newark, USA)
Basal ganglia theta oscillation as a predictor of levodopa-induced dyskinesias

M. Wilken, L. Granda, I. Cruz Varela, M. Rossi, D. Cerquetti, M. Merello (Buenos Aires, Argentina)
Baseline and Longitudinal NSD-ISS Staging of the PPMI Cohort

M. Brumm, T. Simuni, C. Gochanour, L. Chahine, K. Poston, S. Chowdhury, C. Coffey, T. Dam, P. Dibiaso, T. Foroud, M. Fraiser, K. Kieburtz, C. Kopil, K. Merchant, B. Mollenhauer, G. Pagano, J. Seibyl, T. Sherer, D. Stephenson, C. Tanner, E. Tolosa, D. Weintraub, Y. Xiao, A. Siderowf, B. Dunn, K. Marek (Iowa City, USA)
Baseline Data of the Mobilise-D Parkinson Cohort

W. Maetzler, JM. Hausdorff, H. Gaßner, C. Hansen, A. Mirelman, L. Alcock, P. Brown, C. Becker, J. Garcia-Aymerich, L. Cordova-Rivera, P. Ginis, H. Hunter, I. Neatrour, J. Winkler, J. Kudelka, H. Hildesheim, M. Gordon, P. Goerrissen, B. Caulfield, M. Long, C. Schlenstedt, A. Nieuwboer, L. Rochester, AJ. Yarnall (Kiel, Germany)
Baseline lipid traits and the clinical characteristics and disease progression in Huntington’s disease

SR. Zhang, YF. Cheng, HF. Shang (Chengdu, China)
Baseline NSD-ISS stage predicts long term progression and survival in sporadic PD: 10-year PPMI data analysis

P. Gonzalez-Latapi, C. Gochanour, H. Cho, S. Ho Choi, C. Caspell, C. Coffey, M. Brumm, Y. Xiao, DE. Lafontant, C. Venuto, C. Tanner, K. Kieburtz, L. Chahine, A. Siderowf, K. Marek, T. Simuni (Chicago, USA)
Baseline Variables Associated with Apomorphine Sublingual Film Retention

J. Kassubek, J. Schwarz, L. López Manzanares, M. Fonseca, C. Denecke Muhr (Ulm, Germany)
Bedside Assessment of Downgaze Palsy by Amplitude in Patients with Progressive Supranuclear Palsy

T. Xie, M. Padmanaban, W. Abou Chaar, J. Nichols (Chicago, USA)
Behavior medicine perspectives in pre-DBS patients with ET and PD

D. Kim, S. O'Neill, S. Murthy, A. Waters, C. Palmese (Bronx, USA)
Behavioral health characteristics of pre-surgical Focused Ultrasound and Deep Brain Stimulation candidates

D. Kim, S. O'Neill, S. Murthy, A. Waters, C. Palmese (Bronx, USA)
Behind the Prison Gates – Creating a nurse led Parkinson’s healthcare pathway at HMP Dartmoor Prison, UK.

E. Edwards, J. Bradley, B. Morgan (Plymouth, United Kingdom)
Behind the wheel with Parkinson’s-Older patients’ review

M. Khwaja, G. Pun, T. Nanayakkara, R. Miah, A. Chatterjee, N. Butt, T. Zubair (Reading, United Kingdom)
Benefits of Exercise on Mobility, Balance, and Cognition in Community-Dwelling Older Adults: An On-Land vs. In-Water Comparison Study

G. Christofoletti, R. de Oliveira, T. Lino, T. Pontin, C. Lorentz, L. Souza, L. Dias (Campo Grande, Brazil)
Benefits of Parkinson’s Team Training Are Maintained Long-Term

K. Lyons, E. Pollard, D. Beran, C. Hunter(†), H. Cianci, E. Book (Kansas City, USA)
Benzodiazepines in the Management of Restless Legs Syndrome: A Systematic Review and Meta-Analysis

G. Bolner, H. Rodriguez, V. Xavier, A. Petry, M. da Rosa, A. Rossato, M. Felippe, T. Denicol, A. Hilbig (Porto Alegre, Brazil)
Beta peaks as predictor for DBS outcome in Parkinson’s disease

V. Molinari, M. Sure, E. Florin, C. Hartmann, A. Schnitzler (Düsseldorf, Germany)
Beyond Clinical Presentation: Incorporating Neuroimaging and Biofluid Markers to Predict Progression of Parkinson’s Disease

L. Collins-Praino, A. Mcnamara, B. Ellul, I. Baetu, S. Lau, M. Jenkinson (Adelaide, Australia)
Beyond constipation: gastrointestinal phenomena in Parkinson’s disease

MA. Silveira, H. Dourado, G. Procópio, M. Sampaio, IJ. Oliveira, L. Almeida, G. Valença (Salvador, Brazil)
Beyond Memory:A Brain Health Awareness Kit for Spanish-speaking Communities

M. Alosilla, C. Alvarez-Pizzillo, S. Avion-Martinez, J. Cabassa, B. Cavedoni Urbano, L. Crawford, M. de Leon, E. Fernandez Toledo, G. Moya-Gale, S. Perez, N. Walker-Pizarro, H. Shah (Hialeah, USA)
Beyond the Surface: Electromyography in Cervical Dystonia

S. Lagerweij, M. van Egmond, M. Smit, L. Centen, M. van Dijk, JW. Elting, M. Tijssen (Groningen, Netherlands)
Bi-allelic BORCS5 Variants Result In A Wide Spectrum of Progressive Neurodevelopmental Disorders via Lysosomal Dysfunction

NE. Mencacci, G. Minakaki, R. Maroofian, R. de Pace, F. Magrinelli, S. Eldessouky, WJ. Peng, B. Doan, J. Baptista, T. Marton, J. Vogt, JD. Ortigoza-Escobar, L. Martorell, EJ. Kamsteeg, A. Mahmoud, A. Scardamaglia, MS. Zaki, G. Zifarelli, Z. Alhassnan, NW. Wood, M. Schwake, J. Bonifacino, H. Houlden, KP. Bhatia, D. Krainc (Chicago, USA)
Bidirectional interplay between DBS and cognition in Parkinson’s disease: a systematic review

V. Sisodia, A. Malekzadeh, E. Verwijk, P. Schuurman, R. de Bie, B. Swinnen (Amsterdam, Netherlands)
Bidirectional Relationship Between Olfaction and Parkinson’s Disease

J. Kim, S. Bandres-Ciga, K. Heilbron, 23. INC., C. Blauwendraat, A. Noyce (London, United Kingdom)
Bilateral Deep Brain Stimulation in Subthalamic Nucleus versus Globus Pallidus Internus for refractory dystonia

A. Rossato, V. Serafim, G. Sorato, C. Menegon, L. Lima, R. Albuquerque, A. Petry, V. de Souza, H. Rodrigues, P. da Silva, V. Xavier, L. Fernandez (Porto Alegre, Brazil)
Bilateral Fronto-Temporal Lobar Atrophy: An Atypical Magnetic Resonance Imaging Finding in Neuroacanthocytosis

N. Ranjan, AM. Kumar, AB. Ranjan (Patna, India)
Bilateral subthalamic nucleus deep brain stimulation as effective and sustained therapy in Juvenile Parkinson’s disease due to PTPA gene mutations

D. Basson, P. Slabbert, M. Kakaza, C. Schutte, R. van Coller (Kimberley, South Africa)
Bioreactor-produced iPSCs-derived Dopaminergic Neuron-containing Neural Microtissues Innervate and Restore Motor Function in a Dose-dependent Manner in a Parkinson Rat Model

N. Prudon, L. Cordero-Espinoza, M. Abarkan, B. Gurchenkov, C. Morel, M. Lepleux, V. de Luca, N. Pujol, L. Milvoy, P. Morand, F. Moncaubeig, H. Wurtz, L. Poinçot, M. Demarco, A. Jonckeau, J. Plétenka, E. Luquet, K. Schmit, L. Piouceau, S. Guilbert, L. Manache-Alberici, M. Lanero, G. Dabee, T. Dufourd, J. Schroeder, K. Alessandri, E. Bezard, E. Faggiani, M. Feyeux (Bordeaux, France)
Bistriatal hypermetabolism on 18-FDG PET-CT in tardive dyskinesia

C. Héraud, C. Alecu, C. Giordana (NICE, France)
Blautia argi ameliorates the motor impairment of 6-Hydroxydopamine hydrochloride-induced Parkinson’s disease rat model

G. Tian, R. Zhou, J. Lu, W. Shi, R. Li, X. Guo (Xi'an, China)
Blood Pressure Profile of PD-MCI and PDD in Parkinson’s Disease Patients at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia

A. Al Jody, A. Tiksnadi, D. Tunjungsari (Jakarta, Indonesia)
Blood-brain Barrier Breakdown in Dementia with Lewy Bodies

ZC. Chen, J. Gan, Y. Ji (Beijing, China)
Body Mass Index as a Possible Poor Prognostic Factor in Motor and Postural Condition Through the Evaluation of MDS-UPDRS 3.3 – 3.18 in Patients with Parkinson’s.

C. álvarez-Hernández, R. Baños-Betancourt, K. Velazquez-Roman, G. Rivera-Monroy, A. Guerra-Anzaldo, W. Moguel-Cardín, A. Domínguez-García, D. Romero-Terán, A. Regalado-Mustafá, J. Delgado-Uriarte, N. Moreno-Aldama, A. Uribe Leon, M. Unda-Mcfarlane, A. Cervantes-Arriaga, M. Rodriguez-Violante, D. Luna-Escamilla, K. Gonzalez-Rosas, U. Ugalde-Miranda, F. Moralez-Gonzalez, M. Cabrera-Jimenez (Mexico City, Mexico)
Boosting Clinical Trial Power in Parkinson’s Disease with AI-Generated Digital Twins

C. Murray, C. Kusiak, A. Vanderbeek, D. Bertolini, E. Tramel (San Francisco, USA)
Boosting Parkinson’s Disease Diagnosis: How Training Ethiopian Healthcare Workers and Enhancing Community Level Awareness Led to a Surge in Case Identification

MRS. Yinesu (Addis Ababa, Ethiopia)
Botulinum Toxin A Usage in Movement Disorder Division: A Retrospective Chart Review

S. Shaikh, R. Figari Jordan (Charlottesville, USA)
Botulinum Toxin and Deep Brain Stimulation in Dystonia

J. Souza, A. Falcone, R. Barbosa, M. Soares, R. Munhoz, M. Farah, T. Capato, S. Casagrande, M. Cordellini, G. Micheli, J. Limongi, E. Barbosa, C. Listik, R. Cury (Sao Paulo, Brazil)
Brain De-Ironization with Nasal Spray of Iron Chelator in Treatment of Multiple System Atrophy, a Case Trial

A. Amoushahi, A. Sahebkar, P. Moeini, N. Chitsaz (Isfahan, Islamic Republic of Iran)
Brainstem Monoaminergic Degeneration, Cognition, and Autonomic Symptom Progression in Early Parkinson’s Disease

KA. Woo, SY. Kim, HY. Choi, JH. Shin, HJ. Kim (Seoul, Republic of Korea)
Breaking Barriers to Offer Evidence-Based Services for Patients with Parkinson’s Disease in South Africa

S. Govender, S. Haffejee (Johannesburg, South Africa)
Bright Light Therapy: A Novel Non-Pharmacological Approach to Parkinson’s Disease

QK. Lv, YR. Sun, F. Wang, CF. Liu (Suzhou, China)
Broadening the Spectrum of Movement Disorders in Steroid-responsive Encephalopathy associated with Autoimmune Thyroiditis

M S. Majoul, R. Zouari, A. Rachdi, M Z. Saied, D. Ben Mohamed, F. Nabli, S. Ben Sassi (Tunis, Tunisia)
Burden of Movements Disorders at Initiative Plus Center Hospital

P. Kiatoko, K. Luse (KINSHASA, The Democratic Republic of the Congo)
Buspirone/zolmitriptan combination exerts synergistic reduction in dyskinesia without worsening Parkinson disease motor symptomatology

P. Lewitt, G. Stebbins, K. Christensen, M. Thomsen, R. Tan, A. Pretorius (Detroit, USA)